PDT Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.7M Hold
60,000
1.05% 4
2025
Q4
$16.4M Sell
60,000
-2,105
-3% -$572K 1.06% 4
2025
Q3
$16.8M Sell
62,105
-9,297
-13% -$2.53M 1.06% 2
2025
Q2
$19.7M Sell
71,402
-19
-0% -$5.17K 1.11% 1
2025
Q1
$18.9M Buy
71,421
+21
+0% +$5.18K 1.35% 1
2024
Q4
$16.6M Sell
71,400
-6,405
-8% -$1.47M 1.47% 1
2024
Q3
$17.2M Buy
77,805
+17,798
+30% +$3.68M 1.52% 1
2024
Q2
$11.8M Sell
60,007
-52
-0.1% -$10.7K 1.12% 1
2024
Q1
$12.9M Buy
60,059
+59
+0.1% +$12.4K 1.22% 1
2023
Q4
$12.6M Sell
60,000
-23
-0% -$4.91K 1.4% 2
2023
Q3
$12M Buy
60,023
+23
+0% +$4.57K 1.52% 1
2023
Q2
$11.1M Sell
60,000
-32
-0.1% -$5.91K 1.53% 1
2023
Q1
$11.5M Buy
60,032
+28
+0% +$5.06K 1.56% 1
2022
Q4
$10.1M Sell
60,004
-3,796
-6% -$660K 1.63% 1
2022
Q3
$11.3M Sell
63,800
-3,800
-6% -$751K 1.71% 1
2022
Q2
$13.8M Buy
67,600
+7,600
+13% +$1.61M 1.22% 1
2022
Q1
$14.3M Hold
60,000
1.23% 1
2021
Q4
$13.7M Hold
60,000
1.04% 2
2021
Q3
$11.6M Hold
60,000
0.83% 2
2021
Q2
$12.8M Hold
60,000
0.84% 2
2021
Q1
$12.3M Sell
60,000
-6
-0% -$1.18K 0.88% 3
2020
Q4
$10.9M Buy
60,006
+3
+0% +$510 0.74% 2
2020
Q3
$10M Buy
60,003
+3
+0% +$505 0.66% 4
2020
Q2
$9.75M Hold
60,000
0.66% 7
2020
Q1
$10.4M Sell
60,000
-4
-0% -$796 0.82% 9
2019
Q4
$12M Buy
60,004
+4
+0% +$821 0.74% 8
2019
Q3
$12.7M Hold
60,000
0.75% 16
2019
Q2
$11.6M Hold
60,000
0.69% 24
2019
Q1
$9.88M Sell
60,000
-21
-0% -$3.71K 0.56% 49
2018
Q4
$11.3M Buy
60,021
+3
+0% +$554 0.63% 36
2018
Q3
$10.2M Buy
60,018
+18
+0% +$3.03K 0.42% 66
2018
Q2
$9.84M Sell
60,000
-27
-0% -$4.41K 0.37% 89
2018
Q1
$9.71M Buy
60,027
+27
+0% +$4.3K 0.33% 103
2017
Q4
$8.76M Hold
60,000
0.25% 136
2017
Q3
$8.14M Sell
60,000
-294
-0.5% -$37.1K 0.27% 138
2017
Q2
$7.55M Buy
60,294
+294
+0.5% +$35.2K 0.3% 125
2017
Q1
$7.13M Hold
60,000
0.37% 102
2016
Q4
$6.92M Hold
60,000
0.45% 44
2016
Q3
$6.27M Hold
60,000
0.37% 121
2016
Q2
$5.84M Hold
60,000
0.46% 106
2016
Q1
$5.76M Hold
60,000
0.36% 73
2015
Q4
$5.44M Sell
60,000
-29,803
-33% -$2.8M 0.74% 11
2015
Q3
$8.33M Buy
89,803
+29,803
+50% +$2.83M 0.19% 139
2015
Q2
$5.58M Hold
60,000
0.15% 173
2015
Q1
$5.68M Hold
60,000
0.14% 168
2014
Q4
$5.32M Hold
60,000
0.51% 41
2014
Q3
$4.8M Hold
60,000
0.12% 206
2014
Q2
$4.26M Hold
60,000
0.11% 227
2014
Q1
$4.44M Hold
60,000
0.11% 236
2013
Q4
$4.71M Hold
60,000
0.57% 27
2013
Q3
$4.43M Hold
60,000
0.12% 215
2013
Q2
$4.56M Buy
+60,000
New +$3.94M 0.11% 224

Other funds holding CME

PDT Partners's CME Position: Q1 2026 in Review

PDT Partners held its CME Group (CME) position steady in Q1 2026 at 60,000 shares worth $17.7M. The position accounts for 1.05% of the portfolio, ranked #4.

PDT Partners first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.7M in Q2 2025. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • PDT Partners held 60,000 shares of CME Group worth $17.7M as of Q1 2026.
  • PDT Partners left its CME Group share count unchanged in Q1 2026.
  • CME Group made up 1.05% of PDT Partners's portfolio in Q1 2026, its #4 holding.
  • PDT Partners first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • PDT Partners's CME Group position peaked at $19.7M in Q2 2025.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.